Skip to main content

Drugs

Ausgabe 9/2022

Inhalt (9 Artikel)

Current Opinion

From Skepticism to Hope: The Evolving Concept of the Initiation and Use of Sodium-Glucose Cotransporter 2 Inhibitors in Hospitalized Patients

Theocharis Koufakis, Omar G. Mustafa, Ramzi A. Ajjan, Xavier Garcia-Moll, Pantelis Zebekakis, George Dimitriadis, Kalliopi Kotsa

Current Opinion

Prevention and Treatment of Monkeypox

John G. Rizk, Giuseppe Lippi, Brandon M. Henry, Donald N. Forthal, Youssef Rizk

Review Article

In Search of the Optimal Antithrombotic Regimen for Intracerebral Hemorrhage Survivors with Atrial Fibrillation

Teng J. Peng, Catherine Viscoli, Pooja Khatri, Stacey Q. Wolfe, Nirav R. Bhatt, Tarun Girotra, Hooman Kamel, Kevin N. Sheth

Open Access Systematic Review

Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review

Ziad Abuhelwa, Abdurahman Alloghbi, Ali Alqahtani, Misako Nagasaka

AdisInsight Report

Tixagevimab + Cilgavimab: First Approval

Susan J. Keam

AdisInsight Report

Carotegrast Methyl: First Approval

Sohita Dhillon

AdisInsight Report

Oteseconazole: First Approval

Sheridan M. Hoy

Open Access Correction

Correction to: Nirmatrelvir Plus Ritonavir: First Approval

Yvette N. Lamb

Aktuelle Ausgaben